scispace - formally typeset
Search or ask a question
Author

Michel Stoffel

Bio: Michel Stoffel is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Vaccination & Adjuvant. The author has an hindex of 15, co-authored 17 publications receiving 786 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: The improved immunogenicity profile and clinically acceptable reactogenicity of HB-AS04 vaccine are of key importance to provide a more rapid, enhanced, and longer seroprotection to these immunocompromised patients at risk for HB infection.

197 citations

Journal ArticleDOI
02 Dec 2004-Vaccine
TL;DR: Results showed that both vaccines were well tolerated and the general safety profile of HB-AS04 was similar to that of the comparator vaccine.

97 citations

Journal ArticleDOI
TL;DR: In this paper, the authors evaluated the immune response to the new adjuvant of hepatitis B vaccine AS04 (HBV-AS04) in prehemodialysis and hemodialysis patients.

79 citations

Journal Article
TL;DR: In this population of prehemodialysis and hemodialysis patients, the HBV-AS04 was immunogenic, safe, and well-tolerated both as a booster dose after HBV -AS04 or standard hepatitis B vaccine priming.

77 citations

Journal ArticleDOI
TL;DR: A substantial immune response to re‐exposure to hepatitis A antigen after 12 years is shown, which occurs rapidly to ensure protection within the average incubation period of hepatitis A virus.
Abstract: Vaccine-induced hepatitis A antibodies persist up to 10 years in adults, with mathematical models estimating further persistence up to 20-25 years Thirty-one adults received booster inoculations 12 years after their initial vaccination (Havrix 720 ElU at months 0, 1, 6) At the time of booster inoculation, all still had detectable antibodies All but one subject met pre-defined criteria for anamnestic response 14 days after the booster, and all subjects did so after 30 days The subjects' geometric mean titre (GMT) increased rapidly from 242 IU/L at baseline to 3,832 IU/L at day 14 and 5,282 IU/L at day 30 This study shows a substantial immune response to re-exposure to hepatitis A antigen after 12 years, which occurs rapidly to ensure protection within the average incubation period of hepatitis A virus

58 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: Although all the evidence from research on green tea is very promising, future studies are necessary to fully understand its contributions to human health, and advise its regular consumption in Western diets, in which green tea consumption is nowadays limited and sporadic.
Abstract: Tea is the most consumed drink in the world after water. Green tea is a 'non-fermented' tea, and contains more catechins, than black tea or oolong tea. Catechins are in vitro and in vivo strong antioxidants. In addition, its content of certain minerals and vitamins increases the antioxidant potential of this type of tea. Since ancient times, green tea has been considered by the traditional Chinese medicine as a healthful beverage. Recent human studies suggest that green tea may contribute to a reduction in the risk of cardiovascular disease and some forms of cancer, as well as to the promotion of oral health and other physiological functions such as anti-hypertensive effect, body weight control, antibacterial and antivirasic activity, solar ultraviolet protection, bone mineral density increase, anti-fibrotic properties, and neuroprotective power. Increasing interest in its health benefits has led to the inclusion of green tea in the group of beverages with functional properties. However, although all the evidence from research on green tea is very promising, future studies are necessary to fully understand its contributions to human health, and advise its regular consumption in Western diets, in which green tea consumption is nowadays limited and sporadic.

1,732 citations

Journal ArticleDOI
TL;DR: Broad protection against cytohistological outcomes beyond that anticipated for HPV 16/18 and protection against incident infection with HPV 45 and HPV 31 is noted and the vaccine has a good long-term safety profile.

1,601 citations

Journal Article
TL;DR: These updated recommendations represent the final step in the childhood hepatitis A immunization strategy, routine hepatitis A vaccination of children nationwide, and will reinforce existing vaccination programs, extend the benefits associated with hepatitis A vaccinations to the rest of the country, and create the foundation for eventual consideration of elimination of indigenous hepatitis A virus transmission.
Abstract: Routine vaccination of children is an effective way to reduce hepatitis A incidence in the United States. Since licensure of hepatitis A vaccine during 1995-1996, the hepatitis A childhood immunization strategy has been implemented incrementally, starting with the recommendation of the Advisory Committee on Immunization Practices (ACIP) in 1996 to vaccinate children living in communities with the highest disease rates and continuing in 1999 with ACIP's recommendations for vaccination of children living in states, counties, and communities with consistently elevated hepatitis A rates. These updated recommendations represent the final step in the childhood hepatitis A immunization strategy, routine hepatitis A vaccination of children nationwide. Implementation of these recommendations will reinforce existing vaccination programs, extend the benefits associated with hepatitis A vaccination to the rest of the country, and create the foundation for eventual consideration of elimination of indigenous hepatitis A virus transmission. This report updates ACIP's 1999 recommendations concerning the prevention of hepatitis A through immunization (CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 1999:48[No. RR-12]:1-37) and includes 1) new data on the epidemiology of hepatitis A in the era of hepatitis A vaccination of children in selected U.S. areas, 2) results of analyses of the economics of nationwide routine vaccination of children, and 3) recommendations for the routine vaccination of children in the United States. Previous recommendations for vaccination of persons in groups at increased risk for hepatitis A or its adverse consequences and recommendations regarding the use of immune globulin for protection against hepatitis A are unchanged from the 1999 recommendations.

1,061 citations

01 Jan 2008
TL;DR: These revised recommendations by the Advisory Committee on Immunization Practices concerning prevention of plague update previous recommendations (MMWR 1982;31:301-4).
Abstract: These revised recommendations by the Advisory Committee on Immunization Practices concerning prevention of plague update previous recommendations (MMWR 1982;31:301-4). This report includes information and recommendations on vaccination, public health practices, and medical treatment to prevent plague among humans.

1,029 citations

Journal ArticleDOI
TL;DR: The potential benefits and importance of formulation and mechanisms of action of adjuvants are outlined and safety considerations are emphasized in the clinical development of effective adjuvant that will help facilitate effective next-generation vaccines against devastating infectious diseases.
Abstract: Vaccines containing novel adjuvant formulations are increasingly reaching advanced development and licensing stages, providing new tools to fill previously unmet clinical needs. However, many adjuvants fail during product development owing to factors such as manufacturability, stability, lack of effectiveness, unacceptable levels of tolerability or safety concerns. This Review outlines the potential benefits of adjuvants in current and future vaccines and describes the importance of formulation and mechanisms of action of adjuvants. Moreover, we emphasize safety considerations and other crucial aspects in the clinical development of effective adjuvants that will help facilitate effective next-generation vaccines against devastating infectious diseases.

983 citations